Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,754 | 28,213 | 27,939 | 45,413 | 34,510 |
| Marketable Securities | N/A | N/A | 8,291 | 4,673 | 15,622 |
| Receivables | 12,378 | 7,859 | 7,844 | 8,395 | 7,330 |
| Inventories | 10,638 | 8,871 | 12,078 | 6,738 | 5,372 |
| Other current assets | 0 | 2,463 | 0 | 0 | 0 |
| TOTAL | $49,970 | $50,163 | $59,116 | $68,685 | $65,545 |
| Non-Current Assets | |||||
| PPE Net | 574 | 748 | 771 | 529 | 465 |
| Intangibles | 29,000 | 31,802 | 34,439 | 21,445 | 22,154 |
| Other Non-Current Assets | 16,919 | 21,836 | 18,368 | 2,574 | 5,241 |
| TOTAL | $46,494 | $54,386 | $53,578 | $24,548 | $27,859 |
| Total Assets | $96,463 | $104,549 | $112,694 | $93,232 | $93,405 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,396 | 9,994 | 11,093 | 8,980 | 8,037 |
| Other current liabilities | 11,254 | 11,085 | 16,711 | 8,715 | 6,756 |
| TOTAL | $25,668 | $24,150 | $27,804 | $17,695 | $14,792 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,000 | 18,500 | 20,000 | 9,800 | 4,100 |
| Other Non-Current Liabilities | 9,002 | 10,823 | 9,395 | 1,887 | 1,451 |
| TOTAL | $23,923 | $29,314 | $29,319 | $11,616 | $5,492 |
| Total Liabilities | $49,590 | $53,464 | $57,123 | $29,311 | $20,284 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,921 | 15,181 | 15,447 | 15,652 | 16,013 |
| Common Shares | 49,122 | 49,915 | 51,099 | 52,411 | 54,643 |
| Retained earnings | -2,131 | 1,208 | 4,746 | 11,709 | 18,605 |
| Other shareholders' equity | -117 | -38 | -274 | -199 | -127 |
| TOTAL | $46,873 | $51,085 | $55,571 | $63,922 | $73,121 |
| Total Liabilities And Equity | $96,463 | $104,549 | $112,694 | $93,232 | $93,405 |